Stay updated on Pediatric Upadacitinib Pharmacokinetics in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Pediatric Upadacitinib Pharmacokinetics in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pediatric Upadacitinib Pharmacokinetics in Atopic Dermatitis Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:52:11.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the pharmacokinetics, safety, and tolerability evaluation of multiple doses of upadacitinib in pediatric participants with severe atopic dermatitis.
    Difference
    0.1%
    Check dated 2024-06-06T14:37:45.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The participation criteria for the study have been updated to specify that researchers are now looking for participants who meet certain eligibility criteria, including a minimum body weight of 10 kg and, starting from protocol version 6.0, only subjects aged 3 years and older will be enrolled. This change provides more detailed inclusion criteria for potential participants.
    Difference
    17%
    Check dated 2024-05-22T21:20:21.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:15:22.000Z thumbnail image

Stay in the know with updates to Pediatric Upadacitinib Pharmacokinetics in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pediatric Upadacitinib Pharmacokinetics in Atopic Dermatitis Clinical Trial page.